Highlights
NASDAQ: CNAT       Conatus Pharmaceutic
Last Price Today's Change   Day's Range   Trading Volume
0.431   +0.011 (2.62%)  0.42 - 0.454  1,729,200

Overview

 
Avg Volume (4 weeks):874,622
4 Weeks Range:0.363 - 0.454
4 Weeks Price Volatility (%):
74.73%
52 Weeks Range:0.25 - 3.08
52 Weeks Price Volatility (%):
6.40%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Conatus Pharmaceuticals Inc is a biotechnology company. It focuses on the development and commercialization of novel medicines to treat liver disease. The company is developing emricasan, an orally active pan-caspase protease inhibitor, for the treatment of patients with the chronic liver disease. Its operations are divided into only one reportable segment, which is the commercialization and development of pharmaceutical products.

  Be the first to like this.
 


 

3414  4674  636  186 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NIO 4.67+0.30 
 TTNP 0.334+0.084 
 SPY 331.95+1.03 
 SNCA 1.60+0.35 
 EEM 46.23+0.26 
 AVP 5.60-0.05 
 AMD 50.93+1.16 
 CHK 0.661-0.029 
 BAC 34.71-0.01 
 GE 11.81-0.03 
Partners & Brokers